Wouter de Graaff
13Patents
5h-index
14Co-inventors
59Inventor score
Filing activity: May 19, 2004 → Dec 8, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8568374B2 | Intrauterine system | Emerging Cross-Sectional Technologies | 54 | Active |
| US8722037B2 | X-ray visible drug delivery device | Human Necessities | 19 | Active |
| US9345686B2 | Macrocyclic lactone drug delivery system | Human Necessities | 7 | Active |
| US8858977B2 | Drug delivery system | Human Necessities | 5 | Active |
| US8900615B2 | Drug delivery system | Human Necessities | 5 | Active |
| US8808744B2 | Drug delivery system based on polyethylene vinylacetate copolymers | Human Necessities | 5 | Active |
| US8741329B2 | Drug delivery system | Human Necessities | 5 | Active |
| US8481079B2 | Drug delivery system based on polyethylene vinylacetate copolymers | Human Necessities | 5 | Expired |
| US8333983B2 | Drug delivery system | Human Necessities | 4 | Active |
| US10413504B2 | Intravaginal ring drug delivery system | Human Necessities | 4 | Active |
| US10596103B2 | Drug delivery system for delivery of anti-virals | Human Necessities | 4 | Active |
| US8291910B2 | Intrauterine deposit | Emerging Cross-Sectional Technologies | 2 | Active |
| US9198857B2 | Growth promotion of animals by simultaneous release of steroid compounds from a device | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.